PfizerLink is what’s known as a research registry (a database that collects personal and other health information about people). It’s designed to:
- connect people to available Pfizer clinical trials that may be right for them based on their health information; and
- collect information that may help Pfizer learn about medical conditions and related scientific topics. These learnings may help make future scientific discoveries and medical advances possible.
We aim to enroll about 1 million people who represent the diversity of the United States. This includes people with and without medical conditions.
By participating in clinical research, you’re helping make the next breakthrough — for you, for all. Whether you connect to clinical trials or simply answer some questions about yourself and your health through PfizerLink, you can contribute to scientific learning and help make medical advances possible.
If you join PfizerLink, you will be asked to share some information about yourself and your health. PfizerLink will use the information you share to search for available Pfizer clinical trials that may be right for you. We’ll keep checking over time.
If a study is a potential match for you, we’ll connect you to a study doctor in your area who will let you know next steps. Note that if we’re unable to find a Pfizer clinical trial that you may be eligible for, it’s possible that you will not be contacted.
We’ll also use the information you share to learn about medical conditions and related scientific topics that Pfizer researchers are studying. For example, your information might help us learn about the characteristics of people who have a specific medical condition or take a specific medicine. These learnings may help make future scientific discoveries and medical advances possible.
We’re currently connecting PfizerLink participants to available Pfizer clinical trials being conducted across the United States.
We’re aiming to enroll about 1 million people who represent the diversity of the United States. This includes people with and without medical conditions.
To join PfizerLink, you must be a resident of one of the 50 states of the United States or the District of Columbia. You must also be at least 18 years old in most states (at least 19 in Nebraska or Alabama and at least 21 in Mississippi).
We will contact you if we’ve found a potential match for you based on the specific information you’ve shared. You’ll receive an email with information about the Pfizer clinical trial we’ve found. Then a representative of PfizerLink, called a Navigator, will call you, or you can call us, to answer questions and talk about next steps.
If you’re interested and the study still seems like a potential match, the PfizerLink Navigator will connect you to a study doctor in your area. The doctor’s team will tell you more about the study and see if you’re eligible to enroll.
If we’re unable to find a Pfizer clinical trial that you may be eligible for, it's possible that you will not be contacted.
After a PfizerLink Navigator has connected you, the staff at the study location will take you through the next steps to see if you can join the clinical trial. These steps include:
- Informed consent: The study team will review the details of the specific study with you, including possible risks and benefits, so you will know what to expect.
If you decide to participate, you will be asked to sign an informed consent document that is specific to the study. That will confirm you understand the study and are willing to continue with screening and to take part in the study, if you are eligible.
- Screening: You’ll meet with the study doctor and their staff to confirm whether you fit the eligibility criteria and are able to participate. This may include a more detailed review of your medical history and a physical exam. It may also include blood work and additional tests related to your condition.
Participating in the study is always voluntary. The decision to join is personal, and it is yours. You can still take part in PfizerLink, even if you choose not to participate in a Pfizer clinical trial.
Pfizer will use physical, technical, and administrative security measures to protect your personal information. The information that you provide will be kept private and remain confidential.
Pfizer’s privacy and confidentiality practices include the following:
- Only people with roles requiring direct contact with you will have access to information that could directly identify you. All others will only have access to information that is stripped of your name and contact information and replaced with a unique code. This information will be referred to as your “Coded Information.”
- Research analyses will be conducted only with Coded Information.
- When Pfizer publishes research results or shares results with collaborators, it will only publish or share summary information that does not identify any particular individual.
- Obtaining approval of ethical review boards such as the institutional review board for PfizerLink.
Reasonable security safeguards will be used to protect your information, including:
- Limiting access only to people bound by duties of confidentiality and appropriate training;
- Taking steps to minimize the risk that you could be re-identified; and
- Encrypting your information within the PfizerLink secure electronic platform.
PfizerLink maintains robust data privacy and security systems. All Pfizer employees or third parties engaged by Pfizer to work on PfizerLink follow legal, ethical and regulatory requirements, as well as industry standards and best practices.
Pfizer will regularly review its privacy and security practices to help ensure the safety of your information.
Because PfizerLink will collect and use information about you for clinical research purposes, we want to make sure you understand what will happen and agree to it.
The informed consent process is meant to help you understand what to expect as a participant in PfizerLink. This includes explaining the possible benefits and risks of joining, and how your rights, safety, and well-being will be protected.
The informed consent document that you would sign on this website, referred to as a web portal in the informed consent document itself, is specifically for joining PfizerLink. Any clinical trial you consider joining will have its own informed consent document and process that is specific to that study.
There is no cost to you for taking part in PfizerLink. PfizerLink will only collect information and will not have any effect on your regular medical care.
There are no payments to you for taking part in PfizerLink.
(To learn about costs or compensation for participating in clinical trials generally, see the FAQ section “About clinical trials.”)
You are free to stop participating in PfizerLink at any time and for any reason without penalty. Your decision will not affect your regular medical care, any benefits to which you are entitled, or your eligibility to participate in a clinical trial or other research studies.
To stop participating in PfizerLink, sign in to this PfizerLink website and visit your profile. There you will see a link to your consent information. You may withdraw your consent by visiting that link and clicking “withdraw consent.” Withdrawing consent will mean you stop participating in PfizerLink.
After you complete the steps for ending your participation, your account will be deactivated, and no new information will be collected about you or from you by PfizerLink. PfizerLink will not contact you about participating in any further research, and there will be no penalty from Pfizer for ending your participation.
Additional information on what will happen to information from your participation can be found in the PfizerLink informed consent document.
The Pfizer clinical trial alumni website previously known as Pfizer Link has been renamed and moved to a new web domain. Please find it by visiting PfizerClinicalTrialAlumni.com.